New York: Global drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, including in people aged over 65 years, paving the way for the companies to apply for emergency authorisation from US regulators within days American pharmaceutical giant […]
Read MoreMumbai: The country’s largest carrier by domestic market share IndiGo is mulling launching dedicated freighter services amid an expected surge in cargo transportation, particularly to transport COVID-19 vaccine once it is available. The airline has already held preliminary-level discussions with European aviation major Airbus on the type of freighters that could be possibly put into service for dedicated freighter […]
Read MoreNew Delhi: Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. However, SII on Wednesday said it was continuing with the […]
Read MoreJohannesburg: Protesters against Africa’s first COVID-19 vaccine trial burned their face masks Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent. Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI vaccine alliance, Seth Berkley, told an African Union vaccine conference last week. “In general, people in Africa […]
Read MoreLondon: Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine, as efforts to boost manufacturing capacity continue at pace. The alliance, which was forged by Germany, France, Italy and the Netherlands to speed up production of a vaccine, is set […]
Read More